Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Gazprom Neft recommended that dividends be paid for 9 months 2023

11/9/23 SIBN

PhosAgro sales for 9 months of 2023 increased by 2.5%

11/9/23 PHOR

PhosAgro reports for 9 months of 2023 by IFRS

11/9/23 PHOR

Board of Directors of Phosagro recommended dividends

11/9/23 PHOR

Cosmos Hotel Group will open the first five-star hotel in Dombai resort

11/9/23 AFKS

Rosatom's task is to manage maritime traffic on the Northern Sea Route

11/9/23 FESH

Yakovlev to place additional share issue at ₽21.8 per share

11/9/23 IRKT

OGK-2 reported for 9 months of 2023 by IFRS

11/9/23 OGKB

TGC-1 reported for 9 months of 2023 by IFRS

11/9/23 TGKA

Mosenergo reported for 9 months of 2023 by IFRS

11/9/23 MSNG